Investor Resources

FAQs

Investor FAQS

Where is Solid Biosciences corporate headquarters?

Our corporate headquarters are located at 141 Portland Street Fifth Floor, Cambridge, MA 02139, USA.

Telephone: +1 617 337 4680

When was Solid Biosciences founded?

We were originally founded in March 2013.

Where was Solid Biosciences incorporated?

Solid Biosciences was incorporated in Delaware and converted to a corporation in connection with our initial public offering in January 2018.

When did Solid Biosciences go public? What was the price?

Solid Biosciences’ Initial Public Offering occurred on January 25, 2018 at a price of $16.00 per share.

What is Solid Biosciences’ fiscal year?

Our fiscal year ends December 31st.

How is Solid Biosciences’ stock traded?

Our common stock is listed on the Nasdaq Global Select Market under the symbol “SLDB”, and our CUSIP number is 83422E 105.

Who is Solid Biosciences’ transfer agent?

Communications regarding transfer requirements, lost certificates and change of address should be directed to:
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(800) 962-4284

Who is Solid Biosciences’ auditor?

The auditor for Solid Biosciences is PricewaterhouseCoopers, LLP located in Boston, Massachusetts.

Who is Solid Biosciences’ legal counsel?

The legal counsel for Solid Biosciences is Wilmer Cutler Pickering Hale and Dorr LLP located in Boston, Massachusetts.

Where can I find out more about Solid Biosciences?

To find out more about Solid Biosciences visit our webpage at www.solidbio.com

Where can I get the latest corporate news releases and financial reports?

Solid Biosciences’ press release archive can be viewed under the “News & Events” section of the “Investor Relations” page and financial reports are available under the Financials section located at our website www.solidbio.com

How can I view documents Solid Biosciences has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Solid Biosciences’ SEC Filings can be found on www.sec.gov and are also available under the “Financials” section of the “Investor Relations” page located at our website www.solidbio.com

Who makes up the Solid Biosciences’ Executive Management team and Board of Directors?

For a list of the Executive Management team and Board of Directors please visit the “About Us” tab of our website.

Whom should I contact regarding investor inquiries?

For investor inquiries please contact:
 
Kate Niazi-Sai
Solid Biosciences Inc.
Senior Director, Corporate Affairs
EMAIL: Investors@solidbio.com
PHONE: +1 617-337-4680
 
Contact

Contact Solid Biosciences

Kate Niazi-Sai
Senior Director, Corporate Affairs
Investors@solidbio.com
+1 617-337-4680
 
Alerts